Results 181 to 190 of about 374,979 (291)

Low-grade non-muscle-invasive urothelial carcinoma of the bladder in a 16-year-old boy with UGT1A1 polymorphism and Gilbert's syndrome: A case report. [PDF]

Urol Case Rep
N M, H B, Kp N, G MK, Ashok S, Jose Chirayath M, S Thomas R, Raj R, Mohan A, I Thomas A, Mary George T.   +10 more
europepmc   +1 more source

The risk of developing non-carcinogenic effects in children in industrial city in multicompartment contamination with chemical pollutants

, 2020
Андрей Геннадьевич Сетко, Ж.К. K. Мрясова, E.A. Terekhova, А.В. V. Тюрин   +3 more
openalex   +2 more sources

Characterization by two-endpoint comparisons of the genetic toxicity profiles of vinyl chloride and related etheno-adduct forming carcinogens in Drosophila [PDF]

, 1996
Leo Ballering, M.J.M. Nivard, E. Vogel
openalex   +1 more source

Navigating the Genetic Risk of Chemotherapy‐Induced Hearing Loss in the Stria Vascularis

Clinical Pharmacology &Therapeutics, EarlyView.
Cisplatin is a chemotherapy drug that causes permanent hearing loss by damaging a critical tissue lining the inner ear, called the stria vascularis (SV). Currently, the molecular mechanisms of SV damage are largely unknown and the incidence of ototoxicity in patients cannot be reliably predicted.
Tara Lazetic, Deanne Nixie R. Miao, Britt I. Drögemöller, Alain Dabdoub, Julia M. Abitbol   +4 more
wiley   +1 more source

Exposure Registries as a Prevention Tool for Occupational Cancers: Establishing a New Hazardous Drug Registry for Oncology Personnel. [PDF]

Am J Ind Med
Almashat S, Horch M, Chen B, McDiarmid M.   +3 more
europepmc   +1 more source

Effect of administration of the carcinogen dimethylnitrosamine on urinary 7-methylguanine [PDF]

, 1967
V.M. Craddock, PN MAGEE
openalex   +1 more source

Early antitumor activity of oral Langerhans cells is compromised by a carcinogen

, 2022
Yasmin Saba, Itay Aizenbud, Daniela Matanes, Noam Koren, Or Barel, Khalid Zubeidat, Tal Capucha, Eyal David, Luba Eli‐Berchoer, Patrizia Stoitzner, Asaf Wilensky, Ido Amit, Rakefet Czerninski, Simon Yona, Avi‐Hai Hovav   +14 more
openalex   +1 more source

Chemically contaminated aquatic food resources and human cancer risk: retrospective [PDF]

, 1991
Dawe, C. J., Farrington, J. W., Fouts, J. R., Harshbarger, J. C., Murchelano, R. A., Ozonoff, D., Pritchard, J. B., Stegeman, J. J.   +7 more
core   +1 more source

PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature

Clinical Pharmacology &Therapeutics, EarlyView.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou, Estella S. Poloni, José A.G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Teri E. Klein, Mariam R. Habil, Giannoulis Fakis, Rodney F. Minchin, David W. Hein, Sotiria Boukouvala, Andrea Gaedigk   +14 more
wiley   +1 more source

Toward Explainable Carcinogenicity Prediction: An Integrated Cheminformatics Approach and Consensus Framework for Possibly Carcinogenic Chemicals. [PDF]

J Chem Inf Model
Duy HA, Srisongkram T.
europepmc   +1 more source